Author:
Xia Jinkun,Shi Yuyu,Chen Xinxu
Funder
the Guizhou Provincial People’s Hospital Talent Fund
Publisher
Springer Science and Business Media LLC
Reference97 articles.
1. Tao, Y. et al. New insights into immune cells and immunotherapy for thyroid cancer. Immunol. Invest. 52(8), 1039–1064 (2023).
2. Wang, J. et al. Customizing cancer treatment at the nanoscale: A focus on anaplastic thyroid cancer therapy. J. Nanobiotechnol. 21(1), 374 (2023).
3. Bhattacharya, S. et al. Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches. Life Sci. 332, 122110 (2023).
4. Abe, I. & Lam, A. K. Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging. Histol. Histopathol. 36(3), 239–248 (2021).
5. Leandro-Garcia, L. J. & Landa, I. Mechanistic insights of thyroid cancer progression. Endocrinology 164(9), bqad118 (2023).